| Caracteristics | Evolution of newborns | p-Value | |
| Death (n = 10) | Alive (n = 76) | ||
| Class of hypertension | 0.342 | ||
| Preeclampsia | 9 (14.5) | 53 (85.5) | |
| Preeclampsia + chronic hypertension | 1 (20.0) | 4 (80.0) | |
| Gestational hypertension | 0 (0.0) | 16 (100.0) | |
| Chronic hypertension | 0 (0.0) | 3 (100.0) | |
| Eclampsia | 0.468 | ||
| No | 8 (10.7) | 67 (89.3) | |
| Yes | 2 (18.2) | 9 (81.8) | |
| HELLP | 0.821 | ||
| No | 8 (11.3) | 63 (88.7) | |
| Yes | 2 (13.3) | 13 (86.7) | |
| Acute Renal Failure (ARF) | 0.393 | ||
| No | 9 (11.0) | 73 (89.0) | |
| Yes | 1 (25.0) | 3 (75.0) | |
| Antenatal corticosteroid therapy | <0.001 | ||
| No | 3 (4.8) | 60 (95.2) | |
| Yes | 7 (30.4) | 16 (69.6) | |
| Gestational age | 0.012 | ||
| 28 - 32 | 4 (40.0) | 6 (60.0) | |
| 33 - 36 | 5 (13.2) | 33 (86.8) | |
| 37 - 40 | 1 (2.7) | 36 (97.3) | |
| ≥41 | 0 (0.0) | 1 (100.0) | |
| Mode of delivery | 0.138 | ||
| Vaginal | 1 (3.8) | 25 (96.2) | |
| Cesarean | 9 (15.0) | 51 (85.0) | |